SRZN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration...

Stats
Today's Volume	11 124.00
Average Volume	16 966.00
Market Cap	28.72M
EPS	$0 ( 2024-04-03 )
Next earnings date	( $-4.25 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.420
ATR14	$0.150 (1.67%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Li Yang	Buy	10 000	Option (right to buy)
2024-04-24	Li Yang	Buy	5 000	Restricted Stock Unit
2024-04-24	Parker Craig C	Buy	43 000	Option (right to buy)
2024-04-24	Williams Charles O	Buy	13 000	Option (right to buy)
2024-04-24	Williams Charles O	Buy	7 000	Restricted Stock Unit

INSIDER POWER
92.41
Last 99 transactions
Buy: 7 137 981 \| Sell: 808 309

Surrozen, Inc. Correlation

10 Most Positive Correlations
NXTC	0.94
PVBC	0.939
TOI	0.936
HHGCU	0.933
STSA	0.916
JNCE	0.916
PRVA	0.915
FAAR	0.909
VSTA	0.903
LPTX	0.9

10 Most Negative Correlations
NRIM	-0.942
AMRB	-0.937
MDLZ	-0.928
CLRO	-0.928
LYLT	-0.923
STIM	-0.917
PBFS	-0.904
PRDO	-0.903
VLYPO	-0.901
LVHD	-0.901

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Surrozen, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.91M (0.00 %)
EPS:	$-21.33

FY	2023
Revenue:	$0
Gross Profit:	$-1.91M (0.00 %)
EPS:	$-21.33

FY	2022
Revenue:	$12.50M
Gross Profit:	$9.23M (73.85 %)
EPS:	$-11.95

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.556

Financial Reports:

No articles found.

Surrozen, Inc.

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.